Detailed price information for Voyager Therapeut (VYGR-Q) from The Globe and Mail including charting and trades.
Voyager Therapeutics, Inc. stays a Strong Buy as its dual Alzheimer’s programs near key 2026-2027 catalysts. Click for this VYGR update.
Detailed price information for Voyager Therapeut (VYGR-Q) from The Globe and Mail including charting and trades.
Detailed price information for Voyager Therapeut (VYGR-Q) from The Globe and Mail including charting and trades.
LEXINGTON, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging ...
This is the newest page. Registered accounts read further back.